Calimmune
is a biotechnology company that focuses on the development of ex vivo hematopoietic stem cell gene therapy for hematologic diseases... Read moreCalimmune
is a biotechnology company that focuses on the development of ex vivo hematopoietic stem cell gene therapy for hematologic diseases... Read more
News
Sep 12, 2018
BioPortfolio
Calimmune: The Arizona Bioscience Company of the Year is on a Mission to Cure the Uncurable
Mar 10, 2018
BioPortfolio
Calimmune: Calimmune Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27022018 Prices from USD $250
Dec 08, 2017
BioPortfolio
Calimmune: Calimmune Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 15112017 Prices from USD $250
Aug 30, 2017
BioPharma-Reporter
Calimmune: CSL adding scalable stem cell gene therapy tech in $91m Calimmune buy
Aug 30, 2017
Pharmaceutical Business Review
Calimmune: CSL Behring to buy US biotechnology firm Calimmune
Aug 28, 2017
BioCentury
Calimmune: CSL Behring acquires Calimmune
Aug 27, 2017
The Business Journals
Calimmune: $91M deal: CSL acquires California stem cell gene therapy developer
Aug 22, 2017
BioPortfolio
Calimmune: Calimmune Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 25072017 Prices from USD $250
Mar 27, 2017
BioPortfolio
Calimmune: Calimmune Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 10032017 Prices from USD $250
Mar 23, 2017
BioPortfolio
Calimmune: Calimmune Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 23022017 Prices from USD $250
Calimmune Competitors
1
2
3
4
5
6
7
8
9
10